Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › NH

NH

Narayana Hrudayalaya Ltd.
Mid-capHealthcare ↗

What the six lenses say about NH — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1911.8
2026-09-08
VWAP · 1Y anchor
₹1879
+1.7% from VWAP
P/E · TTM
48.5×
TTM EPS ₹39.4
52-week range
65%
position low→high
RSI(14)
52
momentum

Own sector index

Healthcare ↗
Neutral

1M

-1.1%

3M

+7.1%

1Y

+14.5%

Breadth >EMA21

55%

How NH’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD550›

The actual numbers

Price vs VWAP (1y)+1.7%
EMA trend stackMixed
Price vs 200-EMA+2.9%
Price vs 50-EMA+0.4%
RSI(14)52
RS vs Nifty 500 · 3M-4.9%
RS vs sector · 3M-7.6%
52-week range65%
Volume vs 30d avg0.38×
Volume vs 60d avg0.42×
ATR(14) · volatility52.3
Bollinger width · vol contraction0.100
FundamentalD865›

The actual numbers

Return on equity (ROE)20.9%
Return on capital (ROCE)15.4%
Operating margin15.3%
Net margin10.2%
Revenue growth · YoY+41.4%
EPS growth · YoY+1.5%
Debt / equity1.29×

Full 8-quarter history in the financials table below.

ValuationD416›

The actual numbers

P/E (TTM)48.5×
TTM EPS₹39.4
52-week range65%
CatalystD748›

The actual numbers

Earnings & momentum47
Capital actions24
Governance129

Every filing in the corporate-announcements panel below.

FlowD1068›

The actual numbers

Promoter holding63.3%
Delivery · 30d avg61.3%
Up/down-day asymmetry0.9pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D5 + D10 ) ÷ 2 = 7.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
52
Conviction score 52/100 · avg-decile strength 7.5/10
Conviction score52/100›
TechnicalD5›
FundamentalD8›
ValuationD4›
CatalystD7›
FlowD10›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+3.4pp
+1.5pp
+4.9pp
-3.3pp
+11.7pp
+11.1pp
Nifty 500
Broad-market baseline
+3.3pp
+1.5pp
+3.8pp
-4.9pp
+5.9pp
+5.9pp
Sector
Own-sector index
—
—
+2.5pp
-7.6pp
-2.8pp
-7.4pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

NH daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1911.80+53.30

Relative strength

RS vs baseline · rebased to 100

NH ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
140.91+4.51

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)1,3411,4001,3671,4751,5071,6442,1512,594
↳ change QoQ—+4.4%-2.4%+7.9%+2.2%+9.1%+30.8%+20.6%
EBITDA (₹cr)327332325358337401365508
EBITDA margin24.4%23.7%23.8%24.3%22.4%24.4%17.0%19.6%
PAT (₹cr)201199193197197258127224
↳ change QoQ—-1.3%-2.9%+2.0%+0.0%+31.0%-50.8%+76.4%
Net margin15.0%14.2%14.1%13.4%13.1%15.7%5.9%8.6%
EPS (₹)9.929.789.509.659.6212.646.2010.96
D/E————————
YoY growth · Mar '26Revenue +75.9% YoYPAT +13.7% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 18 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Jul '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Jul '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Jul '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Jul '26
    HIGHearnings
    Reply to Clarification- Financial results
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 29 Jun '26
    HIGHearnings
    Clarification - Financial Results
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds NH

Mutual funds holding NH (10)

FundWeightAUM ₹crGrade
Mirae Asset Large & Midcap Gr1.72%45,275
Axis Small Cap Fund Reg Gr1.12%30,089
Mirae Asset Midcap Reg Gr1.93%20,268
DSP Small Cap Reg Gr0.72%20,221
Nippon India Pharma Bns1.80%9,279
Nippon India Pharma Gr1.80%9,279
WhiteOak Capital Mid Cap Reg Gr0.65%6,792
Mirae Asset Multicap Reg Gr1.62%5,470
Mirae Asset Small Cap Reg Gr1.47%5,221
Mirae Asset Flexi Cap Reg Gr1.07%4,393

ETFs holding NH (9)

ETFWeightGrade
Groww BSE Hospitals ETF5.74%
Zerodha Nifty Smallcap 100 ETF1.19%
Mirae Asset Nifty 500 Healthcare ETF1.01%
Motilal Oswal BSE Healthcare ETF0.87%
DSP Nifty Smallcap 250 ETF0.68%
Motilal Oswal Nifty Smallcap 250 ETF0.65%
HDFC Nifty Smallcap 250 ETF0.65%
Mirae Asset Nifty Smallcap 250 ETF0.65%
Groww Nifty Smallcap 250 ETF0.65%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare